GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
170 hedge funds and large institutions have $1.91B invested in GW Pharmaceuticals Plc American Depositary Shares in 2017 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 51 reducing their positions, and 33 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
18% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 51
5% less funds holding
Funds holding: 179 → 170 (-9)
16% less capital invested
Capital invested by funds: $2.28B → $1.91B (-$376M)
24% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 33
33% less call options, than puts
Call options by funds: $42.3M | Put options by funds: $63.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$75.3M |
| 2 |
SCM
Scopia Capital Management
New York
|
+$54.5M |
| 3 |
BlackRock
New York
|
+$19.9M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$13.5M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.2M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$30.2M |
| 3 |
Bank of New York Mellon
New York
|
-$28.3M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$9.39M |
| 5 |
JP
Jana Partners
New York
|
-$7.96M |
GWPH Hedge Fund Activity: Q2 2017 in Review
170 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2017, worth a combined $1.91B — down 16% from $2.28B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of GWPH and 25 opened new positions — a net loss of 8 holders — while 51 trimmed existing stakes and 60 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $75.3M. The largest seller was Fidelity Investments, cutting an estimated $37.2M.
- 170 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2017, down from 179 in Q1 2017.
- Funds reported $1.91B of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2017, down 16% quarter-over-quarter.
- 25 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2017 and 33 closed out, a net change of -8 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2017 was Janus Henderson Group, an estimated $75.3M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2017 was Fidelity Investments, an estimated $37.2M sold.
Based on aggregated 13F filings for Q2 2017.